BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15855244)

  • 21. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients.
    Akbas SH; Bilgen T; Keser I; Tuncer M; Yucetin L; Tosun O; Gultekin M; Luleci G
    Transplant Proc; 2006 Jun; 38(5):1290-2. PubMed ID: 16797284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.
    Pea F; Tavio M; Pavan F; Londero A; Bresadola V; Adani GL; Furlanut M; Viale P
    Antivir Ther; 2008; 13(5):739-42. PubMed ID: 18771060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
    Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
    Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different evolution of trough and dose levels during the first year after transplantation for tacrolimus versus cyclosporine.
    Lemahieu WP; Maes BD; Vanrenterghem Y
    Transplant Proc; 2005 Jun; 37(5):2051-3. PubMed ID: 15964336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute myopathy in a patient with concomitant use of pravastatin and colchicine.
    Alayli G; Cengiz K; Cantürk F; Durmuş D; Akyol Y; Menekşe EB
    Ann Pharmacother; 2005; 39(7-8):1358-61. PubMed ID: 15914514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in heart transplant recipients.
    Lake KD; Aaronson KD; Gorman LE; Pagani FD; Koelling TM
    J Heart Lung Transplant; 2005 Aug; 24(8):990-4. PubMed ID: 16102431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
    Shitrit D; Ollech JE; Ollech A; Bakal I; Saute M; Sahar G; Kramer MR
    J Heart Lung Transplant; 2005 Dec; 24(12):2148-52. PubMed ID: 16364864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
    Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
    Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
    Imamura R; Ichimaru N; Moriyama T; Shi Y; Namba Y; Nonomura N; Matsumiya K; Toki K; Takahara S; Okuyama A
    Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile-Associated Colitis Post-Transplant Is Not Associated with Elevation of Tacrolimus Concentrations.
    Bonatti HJR; Sadik KW; Krebs ED; Sifri CD; Pruett TL; Sawyer RG
    Surg Infect (Larchmt); 2017; 18(6):689-693. PubMed ID: 28650734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation.
    Rodrigo E; Piñera C; de Cos MA; Sánchez B; Ruiz JC; Fernández-Fresnedo G; Palomar R; González-Cotorruelo J; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
    Transpl Int; 2005 Oct; 18(10):1152-7. PubMed ID: 16162102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC; Srun SW; Wood EG; Belsha CW; Marshall DL; Ferdman BR
    J Heart Lung Transplant; 2006 May; 25(5):518-22. PubMed ID: 16678029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction.
    Howard-Thompson A; Hurdle AC; Arnold LB; Finch CK; Sands C; Self TH
    Am J Geriatr Pharmacother; 2008 Mar; 6(1):33-6. PubMed ID: 18396247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy.
    Tang SC; Chan KW; Tang CS; Lam MF; Leung CY; Tse KC; Li CS; Ho YW; Tong MK; Lai KN; Chan TM;
    Nephrol Dial Transplant; 2006 Nov; 21(11):3243-51. PubMed ID: 16877482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cobicistat Significantly Increases Tacrolimus Serum Concentrations in a Renal Transplant Recipient with Human Immunodeficiency Virus Infection.
    Han Z; Kane BM; Petty LA; Josephson MA; Sutor J; Pursell KJ
    Pharmacotherapy; 2016 Jun; 36(6):e50-e53. PubMed ID: 27041642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
    Heilman RL; Mazur MJ; Reddy KS; Moss A; Post D; Mulligan D
    Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R; Chusney G; Loucaidou M; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin-induced elevation of liver enzyme levels.
    Cadle RM; Mansouri MD; Darouiche RO
    Ann Pharmacother; 2006 Jun; 40(6):1186-9. PubMed ID: 16720708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.